Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Motivity has completed the acquisition of Calmanac, a healthcare IT business in the ABA software space, for $11 million. Motivity acquisitions combine Calmanac’s applied behavior analysis practice management capabilities, including scheduling, billing, and payer authorizations, with Motivity’s clinical data collection platform for end-to-end ABA workflows. The Calmanac acquisition supports credential-based scheduling, compliance-oriented billing systems, and cross-department operational coordination for large ABA providers. As a private equity acquisition and platform acquisition, the healthcare M&A deal formalizes a technical integration started in 2023 and expands Motivity’s practice management footprint using Calmanac’s enterprise-grade infrastructure.
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026